A new study by researchers in the Department of Clinical Neuroscience, Karolinska Institutet, has identified 18 potential drug targets for the treatment of multiple sclerosis. The study may pave the ...

Rocky Mountain MS clinic, a Salt Lake City-based provider of specialized care for people living with multiple sclerosis, has ...

A trial using PET scans to test the anti-inflammatory drug PIPE-791 finished enrolling healthy volunteers and patients with ...

In healthy adults, a single low dose of IMP761 continues to be safe and appears to reduce the activity of T-cells, a clinical ...

Aurivo’s 'charity of the year' initiative has raised €660,000 for a range of non-profits since the charity partner programme ...

A study of twins reveals two gut bacteria linked to multiple sclerosis, offering new targets for future treatments.

The multiple sclerosis (MS) disease-modifying therapy (DMT) market across the seven major markets (7MM: the US, France, ...

Circulate Health, a Seattle health longevity startup, today announced $12 million in seed funding to expand its plasma ...

An engineered protein turns off the kind of immune cells most likely to damage tissue as part of type-1 diabetes, hepatitis, ...

Low Medicaid rwimbursement rates make it difficult for providers to keep their pay competitive, leading to staffing shortages ...

UC Riverside study may lead to new treatments for multiple sclerosis. Multiple sclerosis (MS) affects an estimated 2.3 ...